BBIO vs ENTG

Comparison between BridgeBio Pharma Inc (BBIO, Company) and Entegris Inc (ENTG, Company).

BBIO is from the Healthcare sector, while ENTG is from the Technology sector.

5-Year PerformanceBBIO has outperformed ENTG, delivering a return of +9.2% compared to +4.0%

BBIO vs ENTG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BBIO(COMPANY)	ENTG(COMPANY)
Market Cap	$16B	$16B
Max Drawdown	92.80%	97.21%
Sharpe Ratio	1.28	1.31
5Y Beta	1.03	2.54
Industry	Biotechnology	Semiconductor Equipment & Materials
P/E Ratio	-22.15	61.41
Forward P/E	N/A	33.78
PEG Ratio	-3.95	1.43
Dividend Yield	N/A	0.32%
5Y Dividends CAGR	N/A	9.34%
5Y EPS CAGR	-3.14%	-5.89%
Debt to Equity	-116.44%	90.17%
Free Cash Flow Yield	-2.72%	3.10%
P/S Ratio	28.21	5.04
P/B Ratio	123.68	4.44

Market Cap

Winner

BBIO

$16B

ENTG

$16B

Max Drawdown

Winner

BBIO

92.80%

ENTG

97.21%

Sharpe Ratio

BBIO

1.28

Winner

ENTG

1.31

5Y Beta

Winner

BBIO

1.03

ENTG

2.54

Industry

BBIO

Biotechnology

ENTG

Semiconductor Equipment & Materials

P/E Ratio

Winner

BBIO

-22.15

ENTG

61.41

Forward P/E

BBIO

N/A

ENTG

33.78

PEG Ratio

Winner

BBIO

-3.95

ENTG

1.43

Dividend Yield

BBIO

N/A

ENTG

0.32%

5Y Dividends CAGR

BBIO

N/A

ENTG

9.34%

5Y EPS CAGR

Winner

BBIO

-3.14%

ENTG

-5.89%

Debt to Equity

Winner

BBIO

-116.44%

ENTG

90.17%

Free Cash Flow Yield

BBIO

-2.72%

Winner

ENTG

3.10%

P/S Ratio

BBIO

28.21

Winner

ENTG

5.04

P/B Ratio

BBIO

123.68

Winner

ENTG

4.44

BBIO vs ENTG - Historical Returns

Returns include dividend reinvestment.

Period	BBIO	ENTG
1 month	+6.32%	+0.36%
3 months	+18.96%	-2.41%
6 months	+9.15%	+32.13%
1 year	+71.87%	+99.15%
5 years(CAGR)	+9.21%	+4.00%
10 years(CAGR)	N/A	+24.45%
Max(CAGR)	+16.61%	+10.53%

Winner

BBIO

+6.32%

ENTG

+0.36%

Winner

BBIO

+18.96%

ENTG

-2.41%

BBIO

+9.15%

Winner

ENTG

+32.13%

BBIO

+71.87%

Winner

ENTG

+99.15%

5Y(CAGR)

Winner

BBIO

+9.21%

ENTG

+4.00%

10Y(CAGR)

BBIO

N/A

ENTG

+24.45%

Max(CAGR)

Winner

BBIO

+16.61%

ENTG

+10.53%

BBIO vs ENTG - Annual Returns (2000 - 2026)

Returns include dividend reinvestment.

Year	BBIO	ENTG
2026	+4.90%	+62.91%
2025	+171.24%	-12.95%
2024	-32.16%	-12.84%
2023	+463.04%	+87.71%
2022	-55.59%	-52.42%
2021	-73.79%	+45.97%
2020	+114.06%	+89.52%
2019	+27.22%	+70.22%
2018	N/A	-11.08%
2017	N/A	+68.59%
2016	N/A	+40.06%
2015	N/A	+1.30%
2014	N/A	+15.37%
2013	N/A	+22.39%
2012	N/A	+5.40%
2011	N/A	+14.95%
2010	N/A	+38.33%
2009	N/A	+129.57%
2008	N/A	-74.36%
2007	N/A	-19.94%
2006	N/A	+11.78%
2005	N/A	-2.48%
2004	N/A	-22.81%
2003	N/A	+16.50%
2002	N/A	-7.95%
2001	N/A	+56.57%
2000	N/A	-33.12%

BBIO vs ENTG Drawdown Comparison

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The maximum drawdown for ENTG was -97.21%, occurring on Mar 2, 2009. Recovery took 3712 trading sessions.

The current BBIO drawdown is -8.98%. The current ENTG drawdown is -20.82%.

Rank	BBIO	ENTG
#1	-92.80% Feb 8, 2021 - Dec 3, 2025	-97.21% Apr 16, 2002 - Jan 11, 2017
#2	-65.45% Dec 23, 2019 - Nov 24, 2020	-59.32% Nov 29, 2021 - Apr 24, 2026
#3	-44.53% Sep 3, 2019 - Nov 20, 2019	-55.13% Jun 5, 2001 - Mar 25, 2002
#4	-21.99% Dec 31, 2020 - Feb 8, 2021	-54.19% Jul 13, 2000 - Jun 5, 2001
#5	-20.25% Jan 22, 2026 - Jul 9, 2026	-41.79% Jun 22, 2026 - Jul 29, 2026
#6	-16.79% Nov 22, 2019 - Dec 9, 2019	-36.80% Jun 12, 2018 - Apr 8, 2019
#7	-14.67% Jul 22, 2019 - Aug 26, 2019	-33.25% Feb 12, 2020 - May 20, 2020
#8	-12.87% Jul 11, 2019 - Jul 22, 2019	-20.54% Apr 27, 2026 - Jun 15, 2026
#9	-11.32% Jul 9, 2026 - Aug 3, 2026	-18.31% May 3, 2019 - Jul 24, 2019
#10	-6.70% Dec 12, 2019 - Dec 18, 2019	-17.64% Jun 8, 2017 - Sep 12, 2017
#11	-6.15% Jan 2, 2026 - Jan 13, 2026	-17.17% Jan 21, 2021 - Apr 1, 2021
#12	-5.62% Jul 5, 2019 - Jul 11, 2019	-16.69% Apr 8, 2021 - Jun 29, 2021
#13	-5.28% Aug 27, 2019 - Sep 3, 2019	-15.54% Aug 3, 2020 - Sep 30, 2020
#14	-4.46% Dec 1, 2020 - Dec 4, 2020	-15.11% Jan 23, 2018 - Mar 6, 2018
#15	-4.45% Dec 18, 2019 - Dec 20, 2019	-14.93% Mar 21, 2018 - Jun 8, 2018